๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease

โœ Scribed by T Suou; S Yamada; K Hosho; N Yoshikawa; H Kawasaki


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
200 KB
Volume
23
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


We evaluated the mechanism of increased serum con-gens can cause increased levels of serum collagen-recentrations of the 7S fragment of the N-terminal domain lated antigens such as the 7S fragment of the Nof type IV collagen (7S collagen) in chronic liver disease. terminal domain of type IV collagen (7S collagen). 4 We measured the concentrations of hepatic-free and de-Type IV collagen is a main collagenous component of posited 7S collagens after extraction with Tris-HCl the basement membrane. It is synthetized primarily in buffer and bacterial collagenase, then compared them the fat-storing cells [5][6][7] and degraded in the migrating with the serum levels in 8 normal controls and 48 paendothelial cells. 8 7S collagen is the major cross-linking tients with chronic liver disease. The hepatic 7S collagen domain of type IV collagen and is not cleaved off during levels extracted with Tris-HCl buffer and collagenase the assembly of type IV collagen. Each 7S collagen molaccounted for 7% and 93%, respectively, of the total 7S ecule connects four type IV collagens by their N-termicollagen levels in normal controls. Both hepatic 7S collagen levels as well as serum levels increased in accor-nal regions. 9 Serum 7S collagen is thus thought to be dance with the progress of liver disease. Serum levels of derived from either the degradation of extant basement 7S collagen showed a closer correlation with the hepatic membrane, from newly formed type IV collagen that is 7S collagen levels extracted with Tris-HCl buffer (r not being deposited in the tissue, or both. 4 ร… .822), compared with those extracted with collagenase


๐Ÿ“œ SIMILAR VOLUMES


Relationship of serum fibrosis markers w
โœ Robert J. Fontana; Zachary D. Goodman; Jules L. Dienstag; Herbert L. Bonkovsky; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 255 KB ๐Ÿ‘ 1 views

This study determined the utility of a panel of serum fibrosis markers along with routine laboratory tests in estimating the likelihood of histological cirrhosis in a cohort of prior nonresponders with chronic hepatitis C. The relationship between serum markers and quantitative hepatic collagen cont

Serum type III procollagen peptide in al
โœ Massimo Colombo; Giorgio Annoni; Maria Francesca Donato; Dario Conte; Dino Marti ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 467 KB

To assess the value of type I11 procollagen peptide (sPIIIP) as a marker of hepatic fibrosis, sera from 73 patients with alcohol-related liver disease and 30 patients with idiopathic hemochromatosis (IHC) were studied by a specific radioimmunoassay. sPIIIP was increased in 87% of 30 patients with ci

Long-Term Follow-Up of Serum N-Terminal
โœ Kurt Weigand; Pierre-Yves Zaugg; Alain Frei; Arthur Zimmermann ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 354 KB ๐Ÿ‘ 1 views

To evaluate the diagnostic and prognostic significance of the N-terminal propeptide of collagen Type III (Col 1-3) in chronic liver disease, the peptide level was measured in the serum of 4 patients with primary biliary cirrhosis, 5 with chronic persistent hepatitis, 12 with chronic active hepatitis